Global RNA Based Therapeutics Market (Technology, Application, End Users and Geography) - Forecast, 2013 - 2020

www.MarketResearchReports.com

Global RNA Based Therapeutics

Market (Technology,

Application, End Users and

Geography) - Forecast, 2013 -

2020

Category : Pharma & Healthcare

All logos and Images mentioned on this slide belong to their respective owners.

http://www.marketresearchreports.com/


Introduction to Report

Launch Date: September 14, 2014

Number of Pages: 140

Geography Coverage: Global

Available Format: PDF

Price For Single User License: USD 4,515

Price For Site User License: USD 7,515

Price For Global User License: USD 10,515

Delivery Time: Within 24 Hours (During Working Days)



About the Report

RNA based therapeutics market is segmented into technology, application, end-users and geography. Technology segment is further categorized as enabling technologies and enabled technologies.

The segment of enabling technologies comprises of Microarrays, Labeling, Purification, Linear amplification, qRT-PCR and Inhibition; whereas, enabled technologies includes RNA interference technology (RNAi) and RNA antisense technology.



Key Highlights

RNA Therapeutics Market (technology, applications, end user and geography) - Industry Analysis and Forecast, 2013 - 2020 report suggests that the RNA Based Therapeutics Market would reach $1.2 billion by 2020 registering a CAGR of 28.4% during 2014 - 2020.

Due to its ability to render targeted solutions for chronic diseases such as cancer, AIDS, rare genetic disorders, and certain cardiovascular conditions, RNA based therapeutics is expected to significantly impact the global pharmaceutical industry.

RNA based therapeutics has garnered significant attention in the recent years due to its potential to treat variety of chronic diseases such as cancer, diabetes, AIDS, Tuberculosis and certain cardiovascular conditions.



Key Highlights Continues…

This therapeutics is commercially available in the market and marketed as Kynamro and Vitravene respectively. Quark, Alnylam and silence therapeutics are other major players of this market with strong research pipeline in RNA based therapeutics.

Geographically, RNA based therapeutics market is segmented into North America, Europe, Asia-Pacific and LAMEA. Potential regions of the respective geographies are strategically analyzed to provide country wise focus on RNA research activities.

North America dominates the RNA based therapeutics followed by Europe and Asia-Pacific. The key market players belong to North America and are conducting extensive research to commercialize the therapeutics.



Key Benefits:

An in-depth analysis of research and clinical developments within RNA based therapeutics market is provided and light is shed on market dynamics that would prove crucial in understanding the market

Quantitative analysis of the current market and estimations through 2013-2020 would assist strategists to design business strategies to capitalize on the prevailing opportunities in the market

Competitive structure of RNA based therapeutics market is analyzed through Porter’s Five Forces model and provides in-depth understanding of the influencing factors for commercialization of RNA therapeutics



Key Benefits Continues…

Detailed study of the strategies of key leaders, partnerships, acquisitions and clinical trials in the RNA based therapeutics market would be informative for professionals in the corporate sector

Pin-point analysis of geographic segments would assist in identification of most profitable segments to capitalize on



Key Market Segmentation:

Market By Technology

Market By Application

Market By End Users

Market By Geography



Report Coverage

1. Introduction2. Executive Summary3. Market Overview4. Global RNA Based Therapeutics Market By

Technologies, 2013-2020, $Million5. Global RNA Based Therapeutics Market By

Applications, 2013-2020, $Million6. Global RNA Based Therapeutics Market By End Users,

2013-2020, $Million7. Global RNA Based Therapeutics Market By

Geography, 2013-2020, $Million8. Company Profiles

For more details regarding Report coverage see the last slide




Company Coverage

1. Quark Pharmaceuticals, Inc. (USA)2. Alnylam Pharmaceuticals, Inc. (USA)3. Dicerna Pharmaceuticals, Inc. (USA)4. Tekmira Pharmaceuticals Corp. (Canada)5. Benitec Biopharma Limited (Australia)6. Cenix BioScience GmbH (Germany)7. Genzyme Corporation (USA) (A Sanofi Company)8. Silence Therapeutics PLC (UK)9. Sirnaomics, Inc. (USA)

For more details regarding Report coverage see the last slide




Custom Research: Are you an industry professional, entrepreneur,

venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research.

For Any Customization Related query Visit IdeaCenter @http://www.marketresearchreports.com/idea-center

For regular industry updates subscribe to our newsletter at: http://www.marketresearchreports.com/subscribe-to-newsletter

http://www.marketresearchreports.com/idea-center

http://www.marketresearchreports.com/subscribe-to-newsletter

http://www.marketresearchreports.com/subscribe-to-newsletter



How To Buy This Report?

Visit following URL to see Table of Content and purchase this publication:

http://mrr.cm/Zz2

About Market Research Reports, Inc.Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”.

Contact : Amitava SenEmail : [email protected]: +1 302-703-7787 (USA) +91-8762746600 (India)

http://mrr.cm/Zz2

http://mrr.cm/Zz2

mailto:[email protected]
